Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces the development of novel pan-KRAS inhibitors of new chemotypes through ...

A farmland landscape in central Spain where different actions to rewild it have taken place in the last four years.